09:43 ET ACLS Axcelis Tech buyout rumor (4.61 -0.03) We are hearing Street talk that AMAT is in preliminary discussions to buy ACLS; the rationale is that ACLS is a natural fit since the two co's make similar ion implant technology, but ACLS has a significant technology advantage
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.